--- title: "Netlist EVP, CFO Gail M. Sasaki sells 25,000 common shares for $112,250" type: "News" locale: "en" url: "https://longbridge.com/en/news/295986176.md" description: "Netlist Inc. EVP and CFO Gail M. Sasaki sold 25,000 common shares on August 12, 2026, at $4.49 per share, totaling $112,250. Following the transaction, her direct holdings stand at 634,594 shares." datetime: "2026-08-15T01:00:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295986176.md) - [en](https://longbridge.com/en/news/295986176.md) - [zh-HK](https://longbridge.com/zh-HK/news/295986176.md) generator: "portal-rs" --- # Netlist EVP, CFO Gail M. Sasaki sells 25,000 common shares for $112,250 - Netlist EVP and CFO Gail M. Sasaki sold 25,000 common shares on Aug. 12, 2026 at USD 4.49. \* Direct holdings stood at 634,594 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Netlist Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-097412), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [NLST.US](https://longbridge.com/en/quote/NLST.US.md) ## Related News & Research - [Netlist EVP, CFO Gail Sasaki sells 100,000 shares for $690,660](https://longbridge.com/en/news/296417004.md) - [Netlist Shares Sink After Losing Appeal in Patent Case Against Micron](https://longbridge.com/en/news/297818365.md) - [Netlist Stock Falls After Court Rules Against Key Memory Patent Claims](https://longbridge.com/en/news/297818487.md) - [Netlist EVP, CFO Gail M. Sasaki sells 25,000 shares for $99,750](https://longbridge.com/en/news/295286877.md) - [Agenus releases corporate overview presentation on botensilimab-balstilimab neoadjuvant colon cancer data](https://longbridge.com/en/news/297820304.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**